111In-Pentetreotide Uptake Due to COVID-19 Vaccination.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34619700.
- Also identified by DOI 10.1097/RLU.0000000000003935 and PMC identifier 8820749.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 72-year-old woman was referred for whole-body 111In-pentetreotide scintigraphy with SPECT/CT. There was increased uptake of lymphadenopathy in the left axilla and left deltoid muscle. The patient's history revealed that the patient received the first dose of the COVID-19 vaccine 3 days before the 111In-pentetreotide scintigraphy with SPECT/CT. This case demonstrates that the COVID-19 vaccine can cause 111In-pentetreotide uptake in the lymph nodes and the deltoid muscle.
Medical subject headings
- COVID-19 Vaccines
- Indium Radioisotopes
- Somatostatin